Skip to content
ETopical – Lifestyle
Author:
Shanghai Henlius Biotech, Inc.
Henlius reports positive results from ASTRIDE U.S. bridging study for serplulimab in combination with chemotherapy for first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC)
October 27, 2026